414 related articles for article (PubMed ID: 28654630)
1. PROGNOSTIC VALUE OF SUBRETINAL HYPERREFLECTIVE MATERIAL IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION TREATED WITH BEVACIZUMAB.
Pokroy R; Mimouni M; Barayev E; Segev F; Geffen N; Nemet AY; Segal O
Retina; 2018 Aug; 38(8):1485-1491. PubMed ID: 28654630
[TBL] [Abstract][Full Text] [Related]
2. Subretinal hyperreflective material morphology in neovascular age-related macular degeneration: A case control study.
Alex D; Giridhar A; Gopalakrishnan M; Indurkhya S; Madan S
Indian J Ophthalmol; 2021 Jul; 69(7):1862-1866. PubMed ID: 34146045
[TBL] [Abstract][Full Text] [Related]
3. Variable response of subretinal hyperreflective material to anti-vascular endothelial growth factor classified with optical coherence tomography angiography.
Maruyama-Inoue M; Sato S; Yamane S; Kadonosono K
Graefes Arch Clin Exp Ophthalmol; 2018 Nov; 256(11):2089-2096. PubMed ID: 30173338
[TBL] [Abstract][Full Text] [Related]
4. CORRELATION BETWEEN OPTICAL COHERENCE TOMOGRAPHIC HYPERREFLECTIVE FOCI AND VISUAL OUTCOMES AFTER ANTI-VEGF TREATMENT IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION AND POLYPOIDAL CHOROIDAL VASCULOPATHY.
Lee H; Ji B; Chung H; Kim HC
Retina; 2016 Mar; 36(3):465-75. PubMed ID: 26076214
[TBL] [Abstract][Full Text] [Related]
5. Macular Morphology and Visual Acuity in Year Five of the Comparison of Age-related Macular Degeneration Treatments Trials.
Jaffe GJ; Ying GS; Toth CA; Daniel E; Grunwald JE; Martin DF; Maguire MG;
Ophthalmology; 2019 Feb; 126(2):252-260. PubMed ID: 30189282
[TBL] [Abstract][Full Text] [Related]
6. Combined fluorescein angiography and spectral-domain optical coherence tomography imaging of classic choroidal neovascularization secondary to age-related macular degeneration before and after intravitreal ranibizumab injections.
Coscas F; Querques G; Forte R; Terrada C; Coscas G; Souied EH
Retina; 2012 Jun; 32(6):1069-76. PubMed ID: 22466476
[TBL] [Abstract][Full Text] [Related]
7. CORRELATION OF SUBRETINAL HYPERREFLECTIVE MATERIAL MORPHOLOGY AND VISUAL ACUITY IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.
Kumar JB; Stinnett S; Han JIL; Jaffe GJ
Retina; 2020 May; 40(5):845-856. PubMed ID: 31305505
[TBL] [Abstract][Full Text] [Related]
8. PROGNOSTIC VALUE OF HYPERREFLECTIVE FOCI IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION TREATED WITH BEVACIZUMAB.
Segal O; Barayev E; Nemet AY; Geffen N; Vainer I; Mimouni M
Retina; 2016 Nov; 36(11):2175-2182. PubMed ID: 27078799
[TBL] [Abstract][Full Text] [Related]
9. Prognosti implications of pigment epithelial detachment in bevacizumab (avastin)-treated eyes with age-related macular degeneration and choroidal neovascularization.
Freeman WR; Kozak I; Yuson RM; Nigam N; Cheng L; Mojana F
Retina; 2011 Oct; 31(9):1812-8. PubMed ID: 21866073
[TBL] [Abstract][Full Text] [Related]
10. PREDICTING RESPONSE OF EXUDATIVE AGE-RELATED MACULAR DEGENERATION TO BEVACIZUMAB BASED ON SPECTRALIS OPTICAL COHERENCE TOMOGRAPHY.
Segal O; Barayev E; Nemet AY; Mimouni M
Retina; 2016 Feb; 36(2):259-63. PubMed ID: 26200510
[TBL] [Abstract][Full Text] [Related]
11. Intravitreal bevacizumab for previously treated choroidal neovascularization from age-related macular degeneration.
Goff MJ; Johnson RN; McDonald HR; Ai E; Jumper JM; Fu A
Retina; 2007; 27(4):432-8. PubMed ID: 17420694
[TBL] [Abstract][Full Text] [Related]
12. Intravitreal bevacizumab in vascular pigment epithelium detachment as a result of subfoveal occult choroidal neovascularization in age-related macular degeneration.
Ach T; Hoeh AE; Ruppenstein M; Kretz FT; Dithmar S
Retina; 2010 Oct; 30(9):1420-5. PubMed ID: 20543764
[TBL] [Abstract][Full Text] [Related]
13. Macular Atrophy in Neovascular Age-Related Macular Degeneration with Monthly versus Treat-and-Extend Ranibizumab: Findings from the TREX-AMD Trial.
Abdelfattah NS; Al-Sheikh M; Pitetta S; Mousa A; Sadda SR; Wykoff CC;
Ophthalmology; 2017 Feb; 124(2):215-223. PubMed ID: 27863845
[TBL] [Abstract][Full Text] [Related]
14. One-year outcomes of less frequent bevacizumab in age-related macular degeneration.
Sonmez K; Sonmez PA; Ozkan SS; Atmaca LS
Retina; 2011 Apr; 31(4):645-53. PubMed ID: 21358363
[TBL] [Abstract][Full Text] [Related]
15. Identification and Quantification of the Angiofibrotic Switch in Neovascular AMD.
Roberts PK; Zotter S; Montuoro A; Pircher M; Baumann B; Ritter M; Hitzenberger CK; Schmidt-Erfurth U
Invest Ophthalmol Vis Sci; 2019 Jan; 60(1):304-311. PubMed ID: 30657855
[TBL] [Abstract][Full Text] [Related]
16. Intravitreal bevacizumab (Avastin) treatment of neovascular age-related macular degeneration.
Emerson MV; Lauer AK; Flaxel CJ; Wilson DJ; Francis PJ; Stout JT; Emerson GG; Schlesinger TK; Nolte SK; Klein ML
Retina; 2007; 27(4):439-44. PubMed ID: 17420695
[TBL] [Abstract][Full Text] [Related]
17. Association of Vascular Versus Avascular Subretinal Hyperreflective Material With Aflibercept Response in Age-related Macular Degeneration.
Kawashima Y; Hata M; Oishi A; Ooto S; Yamashiro K; Tamura H; Miyata M; Uji A; Ueda-Arakawa N; Tsujikawa A
Am J Ophthalmol; 2017 Sep; 181():61-70. PubMed ID: 28669776
[TBL] [Abstract][Full Text] [Related]
18. Intravitreal therapies for non-neovascular age-related macular degeneration with intraretinal or subretinal fluid.
Cuesta-Lasso M; Vieira-Barros A; Dolz-Marco R; Roig-Revert MJ; Badal J; Amselem L; Díaz-Llopis M; Gallego-Pinazo R
Arch Soc Esp Oftalmol; 2017 Mar; 92(3):101-106. PubMed ID: 27912913
[TBL] [Abstract][Full Text] [Related]
19. A paradigm shift in imaging biomarkers in neovascular age-related macular degeneration.
Schmidt-Erfurth U; Waldstein SM
Prog Retin Eye Res; 2016 Jan; 50():1-24. PubMed ID: 26307399
[TBL] [Abstract][Full Text] [Related]
20. Macular Morphology and Visual Acuity in the Second Year of the Comparison of Age-Related Macular Degeneration Treatments Trials.
Sharma S; Toth CA; Daniel E; Grunwald JE; Maguire MG; Ying GS; Huang J; Martin DF; Jaffe GJ;
Ophthalmology; 2016 Apr; 123(4):865-75. PubMed ID: 26783095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]